Azura Ophthalmics

Acquired

Azura Ophthalmics is a biotech company in Tel Aviv, Israel, founded in 2014. It has raised $36.0M across 3 rounds, most recently a $20.0M Series C in October 2020.

Headquarters
Tel Aviv
Employees
1–10
Founded
2014
Business Model
B2B
Total Funding
$36.0M
Last Round
$20.0M Series COct 2020
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.

About

Azura Ophthalmics developed ophthalmic keratolytics to treat underserved ophthalmic conditions, drawing on expertise in ocular surface diseases and drug development. Its approach focused on using keratolytics for lid margin and ocular surface diseases. The therapeutic strategy targeted underlying pathophysiology to improve the signs, symptoms, and burden of ophthalmic conditions.

Summary

It lists 1–10 employees. It has raised $36.0M in total across 3 rounds, most recently a $20.0M Series C round in Oct 2020. Investors include OrbiMed, Brandon Capital Partners and TPG Biotechnology Partners.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries COct 2020
$20.0M

Sign up to see all 3 events

Funding: Seed through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Azura Ophthalmics on Indexed.vc
<a href="https://indexed.vc/companies/azura-ophthalmics"><img src="https://indexed.vc/api/badge/company/azura-ophthalmics" alt="Azura Ophthalmics on Indexed.vc" width="260" height="76" /></a>